T1	chemical 0 8	Orlistat
T2	disease_or_phenotypic_feature 64 82	growth retardation
T3	chemical 160 169	cisplatin
T4	disease_or_phenotypic_feature 192 198	anemia
T5	disease_or_phenotypic_feature 204 211	obesity
T6	chemical 253 259	oxygen
T7	chemical 315 334	interleukin-1 alpha
T8	chemical 357 364	antigen
T9	disease_or_phenotypic_feature 407 445	delayed-type hypersensitivity response
T10	chemical 478 486	antigens
T11	chemical 602 605	THA
T12	chemical 607 614	Tacrine
T13	chemical 641 645	drug
T14	disease_or_phenotypic_feature 668 685	cognitive deficit
T15	disease_or_phenotypic_feature 689 708	Alzheimer's disease
T16	disease_or_phenotypic_feature 730 741	hypophyseal
T17	chemical 759 773	growth hormone
T18	chemical 836 843	hormone
T19	chemical 844 852	cortisol
T20	disease_or_phenotypic_feature 906 914	diabetes
T21	disease_or_phenotypic_feature 916 929	heart failure
T22	disease_or_phenotypic_feature 934 946	hypertension
T23	disease_or_phenotypic_feature 956 974	Cushing's syndrome
T24	disease_or_phenotypic_feature 988 1001	renal failure
T25	chemical 1066 1074	antigens
T26	disease_or_phenotypic_feature 1102 1108	cancer
T27	chemical 1206 1217	candesartan
T28	disease_or_phenotypic_feature 1262 1275	renal failure
T29	disease_or_phenotypic_feature 1280 1292	hyperkalemia
T30	chemical 1384 1393	inhibitor
T31	chemical 1425 1437	theophylline
T32	chemical 1482 1486	drug
T33	disease_or_phenotypic_feature 1495 1508	liver disease
T34	disease_or_phenotypic_feature 1530 1543	heart failure
T35	disease_or_phenotypic_feature 1584 1600	bipolar disorder
T36	disease_or_phenotypic_feature 1613 1621	seizures
T37	chemical 1623 1630	alcohol
T38	chemical 1650 1654	drug
T39	disease_or_phenotypic_feature 1663 1674	Hypokalemia
T40	chemical 1679 1689	anesthetic
T41	disease_or_phenotypic_feature 1704 1722	Metabolic syndrome
T42	disease_or_phenotypic_feature 1788 1802	hyperlipidemia
T43	disease_or_phenotypic_feature 1804 1820	hyperinsulinemia
T44	chemical 1822 1829	glucose
T45	disease_or_phenotypic_feature 1846 1853	obesity
T46	chemical 1855 1865	Anesthesia
T47	disease_or_phenotypic_feature 1870 1878	cataract
T48	disease_or_phenotypic_feature 1903 1913	Lung tumor
T49	chemical 1945 1956	sphingosine
T50	chemical 1959 1968	phosphate
T51	chemical 1969 1976	agonist
T52	chemical 2006 2012	oxygen
T53	disease_or_phenotypic_feature 2042 2049	obesity
T54	disease_or_phenotypic_feature 2094 2097	VHL
T55	chemical 2136 2142	oxygen
T56	chemical 2226 2233	biology
T57	disease_or_phenotypic_feature 2237 2253	breast carcinoma
T58	chemical 2298 2306	hormonal
T59	chemical 2416 2428	Fenfluramine
T60	disease_or_phenotypic_feature 2469 2476	seizure
T61	disease_or_phenotypic_feature 2504 2519	Dravet syndrome
T62	disease_or_phenotypic_feature 2534 2541	seizure
T63	chemical 2569 2580	stiripentol
T64	chemical 2606 2610	drug
T65	chemical 2622 2632	Anesthesia
T66	disease_or_phenotypic_feature 2636 2648	cleft palate
T67	disease_or_phenotypic_feature 2678 2690	hypocalcemia
T68	disease_or_phenotypic_feature 2692 2708	hypophosphatemia
T69	chemical 2721 2725	acid
T70	chemical 2794 2813	parathyroid hormone
T71	chemical 2832 2842	cyclic AMP
T72	missed_disease_or_phenotypic_feature 58 63	tumor
R1	treats Arg1:T1 Arg2:T72	
R2	treats Arg1:T3 Arg2:T72	
R3	treats Arg1:T12 Arg2:T14	
R4	treats Arg1:T12 Arg2:T15	
R5	treats Arg1:T11 Arg2:T14	
R6	treats Arg1:T11 Arg2:T15	
T73	corrected_chemical 622 645	anticholinesterase drug
R7	treats Arg1:T73 Arg2:T14	
R8	treats Arg1:T73 Arg2:T15	
R9	causes_or_contributes_to Arg1:T19 Arg2:T20	
R10	causes_or_contributes_to Arg1:T19 Arg2:T21	
R11	causes_or_contributes_to Arg1:T19 Arg2:T22	
R12	causes_or_contributes_to Arg1:T19 Arg2:T23	
R13	causes_or_contributes_to Arg1:T19 Arg2:T24	
T74	missed_disease_or_phenotypic_feature 948 954	stroke
T75	missed_disease_or_phenotypic_feature 976 983	obesity
R14	causes_or_contributes_to Arg1:T19 Arg2:T74	
R15	causes_or_contributes_to Arg1:T19 Arg2:T75	
R16	causes_or_contributes_to Arg1:T27 Arg2:T28	
R17	causes_or_contributes_to Arg1:T27 Arg2:T29	
T76	corrected_chemical 1380 1393	ACE inhibitor
R18	causes_or_contributes_to Arg1:T76 Arg2:T29	
R19	causes_or_contributes_to Arg1:T76 Arg2:T28	
T77	missed_disease_or_phenotypic_feature 1238 1253	adverse effects
R20	causes_or_contributes_to Arg1:T27 Arg2:T77	
T78	missed_disease_or_phenotypic_feature 1348 1363	adverse effects
R21	causes_or_contributes_to Arg1:T76 Arg2:T78	
T79	corrected_chemical 1945 1976	sphingosine 1-phosphate agonist
T80	missed_chemical 1977 1983	FTY720
R22	causes_or_contributes_to Arg1:T80 Arg2:T48	
R23	causes_or_contributes_to Arg1:T79 Arg2:T48	
T81	corrected_chemical 1993 2012	enteral foam oxygen
R24	treats Arg1:T81 Arg2:T53	
T82	corrected_disease_or_phenotypic_feature 2458 2476	convulsive seizure
R25	treats Arg1:T63 Arg2:T62	
R26	treats Arg1:T59 Arg2:T82	
R27	treats Arg1:T59 Arg2:T61	
